Safety of Recombinant Adeno-Associated Virus Type 2–RPE65 Vector Delivered by Ocular Subretinal InjectionSamuel G. Jacobson, William W. Hauswirth, Sharon Schwartz et al.|Molecular Therapy|2006Cited by 223
881. Safety, Efficacy and Biodistribution of Recombinant AAV2-RPE65 Vector Delivered by Ocular Subretinal InjectionSamuel G. Jacobson, William W. Hauswirth, Gregory M. Acland et al.|Molecular Therapy|2006Cited by 0